HBM Healthcare Investments AG (CH001262)

BRIEF

published on 06/17/2024 at 17:58, 5 months 5 days ago

HBM Healthcare Investments Shareholders Approve All Proposals

Board Of Directors Compensation Shareholders’ Meeting Par Value Repayment HBM Healthcare
PRESS RELEASE

published on 06/17/2024 at 17:53, 5 months 5 days ago

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
HBM Healthcare Investments AG shareholders approve all Board of Directors' proposals at the Shareholders’ Meeting. Details on re-elected board members, compensation, and par value repayment announced

Board Of Directors Compensation Shareholders' Meeting HBM Healthcare Investments AG Par Value Repayment
BRIEF

published on 06/17/2024 at 17:51, 5 months 5 days ago

HBM Healthcare Investments AG Reports Key Figures for Mid-June 2024

Financial Performance Net Asset Value HBM Healthcare Investments Share Price June 2024
PRESS RELEASE

published on 06/17/2024 at 17:46, 5 months 5 days ago

Key Figures 15.06.2024
HBM Healthcare Investments AG reports key figures for June 15, 2024, including NAV and share price performance. Total net assets reach 1.717 million CHF

Performance HBM Healthcare Investments AG Key Figures NAV Net Assets
BRIEF

published on 06/03/2024 at 17:51, 5 months 19 days ago

HBM Healthcare Investments Releases Key Figures for May 2024

Net Asset Value HBM Healthcare Investments Financial Figures Share Price May 2024
PRESS RELEASE

published on 06/03/2024 at 17:46, 5 months 19 days ago

Key Figures 31.05.2024
HBM Healthcare Investments AG announces key figures as of 31.05.2024: NAV at 256.74 CHF, share price at 208.00 CHF. Performance percentages for MTD, FYTD, CYTD included

HBM Healthcare Investments AG Key Figures Share Price NAV Performance Percentages
BRIEF

published on 05/28/2024 at 14:06, 5 months 25 days ago

HBM Portfolio Company Yellow Jersey Therapeutics to Be Acquired for $1.25 Billion

Acquisition HBM Yellow Jersey Therapeutics Johnson & Johnson Numab Therapeutics
PRESS RELEASE

published on 05/28/2024 at 14:01, 5 months 25 days ago

HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM Healthcare Investments announces Yellow Jersey Therapeutics acquisition by Johnson & Johnson for USD 1.25 billion. Transaction increases NAV per HBM share by CHF 8.70 (+3.5%) with expected cash inflow of USD 78 million

Acquisition HBM Healthcare Investments Biotech Yellow Jersey Therapeutics Johnson & Johnson
BRIEF

published on 05/22/2024 at 18:22, 6 months ago

HBM Healthcare Investments' Swixx BioPharma Boosts Sales through Latin American Acquisition

Acquisition HBM Healthcare Investments Latin America Swixx BioPharma Laboratorios Biopas
PRESS RELEASE

published on 05/22/2024 at 18:17, 6 months ago

HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
Swixx BioPharma, a portfolio company of HBM Healthcare Investments, expands into Latin America with acquisition of Laboratorios Biopas Group, boosting sales and profits

Acquisition HBM Healthcare Investments Latin America Biopharmaceutical Swixx BioPharma

Published on 11/22/2024 at 23:55, 6 hours 45 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 7 hours 10 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 7 hours 35 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 7 hours 35 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 8 hours 10 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 12 hours 25 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 12 hours 40 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 12 hours 46 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 13 hours 44 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 14 hours 40 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 16 hours 5 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 23 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 11 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News